0001062993-24-004273.txt : 20240223
0001062993-24-004273.hdr.sgml : 20240223
20240223163716
ACCESSION NUMBER: 0001062993-24-004273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOKOLOV JACQUE J
CENTRAL INDEX KEY: 0001282803
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40901
FILM NUMBER: 24672019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lucid Diagnostics Inc.
CENTRAL INDEX KEY: 0001799011
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 825488042
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212 949 4319
MAIL ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-22
0001799011
Lucid Diagnostics Inc.
LUCD
0001282803
SOKOLOV JACQUE J
360 MADISON AVENUE
25TH FLOOR
NEW YORK
NY
10017
1
0
0
0
0
Employee stock option (right to buy)
1.23
2024-02-22
4
A
0
150000
0
A
2034-02-22
Common stock
150000
150000
D
One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025.
/s/ Michael A. Gordon, by power of attorney
2024-02-23
EX-24
2
exhibit24.txt
POA
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby makes, constitutes and
appoints each of Michael A. Gordon and Dennis M. McGrath, or either of them
acting singly, and with full power of substitution and resubstitution, the
undersigned's true and lawful attorney-in-fact (each of such persons and
their substitutes being referred to herein as the "Attorney-in-Fact"),
with full power to act for the undersigned and in the undersigned's name,
place and stead, in any and all capacities, to:
1. Prepare, execute, and submit to the Securities and Exchange Commission
("SEC") a Form ID, including amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports required or
considered by the Attorney-in-Fact to be advisable under Section 13 or
Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") or any
rule or regulation of the SEC;
2. Prepare, execute and submit to the SEC, Lucid Diagnostics Inc.
(the "Company"), and/or any national securities exchange on which the
Company's securities are listed any and all reports (including any amendments
thereto) the undersigned is required to file with the SEC, or which the
Attorney-in-Fact considers it advisable to file with the SEC, under Section 13
or Section 16 of the Exchange Act or any rule or regulation thereunder, or
under Rule 144 under the Securities Act of 1933 ("Rule 144"), with respect to
any security of the Company, including Forms 3, 4 and 5, Schedules 13D and 13G,
and Forms 144; and
3. Obtain, as the undersigned's representative and on the undersigned's behalf,
information regarding transactions in the Company's equity securities from any
third party, including the Company and any brokers, dealers, employee benefit
plan administrators and trustees, and the undersigned hereby authorizes any
such third party to release any such information to the Attorney-in-Fact.
The undersigned acknowledges that:
a) This Power of Attorney authorizes, but does not require, the
Attorney-in-Fact to act in his or her discretion on information provided to
such Attorney-in-Fact without independent verification of such information;
b) Any documents prepared or executed by the Attorney-in-Fact on behalf of the
undersigned pursuant to this Power of Attorney will be in such form and will
contain such information as the Attorney-in-Fact, in his or her discretion,
deems necessary or desirable;
c) Neither the Company nor the Attorney-in-Fact assumes any liability for the
undersigned's responsibility to comply with the requirements of Section 13 or
Section 16 of the Exchange Act or Rule 144, any liability of the undersigned
for any failure to comply with such requirements, or any liability of the
undersigned for disgorgement of profits under Section 16(b) of the Exchange
Act; and
d) This Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under Section 13 or Section
16 of the Exchange Act, including, without limitation, the reporting
requirements under Section 13 or Section 16 of the Exchange Act.
The undersigned hereby grants to the Attorney-in-Fact full power and
authority to do and perform each and every act and thing requisite, necessary
or advisable to be done in connection with the foregoing, as fully, to all
intents and purposes, as the undersigned might or could do in person, hereby
ratifying and confirming all that the Attorney-in-Fact, or his or her
substitute or substitutes, shall lawfully do or cause to be done by authority
of this Power of Attorney.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 4 or 5 or Schedules 13D or
13G or Forms 144 with respect to the undersigned's holdings of and transactions
in securities of the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the Attorney-in-Fact. This Power of Attorney
revokes all previous powers of attorney with respect to the subject matter of
this Power of Attorney.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney
as of March 10, 2023.
/s/ Jacque J. Sokolov
Name: Jacque J. Sokolov